The Supreme Court today dismissed
a PIL seeking a probe against Ranbaxy Laboratories Ltd for allegedly manufacturing and selling substandard medicines. The PIL was rejected due to lack of evidence against the company. A Bench of Justices A K Patnaik and Ranjan Gogoi said that it cannot decide the plea against the company on the basis of a judgement passed by a US court. However, the Bench allowed the petitioner advocate to file a fresh petition if he finds some evidence against the company in support of his allegation.